日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liver receptor homolog-1: structures, related diseases, and drug discovery

肝脏受体同源物-1:结构、相关疾病和药物发现

Wu, Tong; Lu, Zhi-Fang; Yu, Hao-Nan; Wu, Xi-Shan; Liu, Yang; Xu, Yong

Discovery and pharmacological characterization of 1,2,3,4-tetrahydroquinoline derivatives as RORγ inverse agonists against prostate cancer.

发现并药理学表征 1,2,3,4-四氢喹啉衍生物作为 RORγ 反向激动剂对抗前列腺癌

Wu Xi-Shan, Luo Xiao-Yu, Li Cheng-Chang, Zhao Xiao-Fan, Zhang Cheng, Chen Xiao-Shan, Lu Zhi-Fang, Wu Tong, Yu Hao-Nan, Peng Chao, Hu Qing-Qing, Shen Hui, Xu Yong, Zhang Yan

Aspirin suppresses hepatocellular carcinoma progression by inhibiting platelet activity

阿司匹林通过抑制血小板活性来抑制肝细胞癌进展

Li-Jun Zhao, Zhi-Yin Wang, Wei-Ting Liu, Li-Li Yu, Hao-Nan Qi, Jie Ren, Chen-Guang Zhang

Gardenia Iridoid Glucosides Protect Against α-Naphthalene Isothiocya-Nate-Induced Cholestatic Rats Through Activation of the FXR-SHP Signaling Pathway

栀子环烯醚萜苷通过激活 FXR-SHP 信号通路保护 α-萘异硫氰酸酯诱导的胆汁淤积大鼠

Meng Xu #, Ke Che #, Cong Wang #, Ya-Ru Chen, Meng-Yuan Chen, Guang-Lei Zhang, Hao Yu, Hao-Nan Xu, Ya-Bao Li, Ping Sheng, Hao Chen

Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CL(pro): Inhibition potentials, covalent binding sites and inhibitory mechanisms

大齿葡萄中的黄酮类化合物作为SARS-CoV-2 3CL(pro)的共价抑制剂:抑制潜力、共价结合位点和抑制机制

Xiong, Yuan; Zhu, Guang-Hao; Zhang, Ya-Ni; Hu, Qing; Wang, Hao-Nan; Yu, Hao-Nan; Qin, Xiao-Ya; Guan, Xiao-Qing; Xiang, Yan-Wei; Tang, Hui; Ge, Guang-Bo